Skip to main content
. Author manuscript; available in PMC: 2019 Jun 12.
Published in final edited form as: Circulation. 2018 Apr 16;137(24):2572–2582. doi: 10.1161/CIRCULATIONAHA.117.031912

Table 2.

Smoking status and cardiac structure and function assessed by CMR at Visit 3

Model 1
Model 2
Never Smoker
(n=791)
Former Smoker
(n=198)
Current Smoker
(N=103)
Never Smoker
(n=791)
Former Smoker
(n=198)
Current Smoker
(n=103)
Variable β (95%CI) β (95%CI) β (95%CI) β (95%CI)
LVEDVI, ml/m2 Ref. −22.27 (−4.55, 0.14) −1.86 (−4.81, 1.08) Ref. −2.09 (−4.36, 0.18) −2.35 (−5.29, 0.60)
LVESVI, ml/2 Ref. −1.06 (−2.55, 0.43) 0.12 (−1.80, 2.05) Ref. −1.02 (−1.92, 1.94) 0.01 (−1.92, 1.94)
SVI, ml/2 Ref. −1.21 (−2.68, 0.25) −1.99 (−3.88, 0.10) Ref. −1.07 (−2.53, 0.39) −2.35 (−4.24, −0.47)
LVEF, % Ref. 0.01 (−1.41, 1.43) −0.75 (−2.58, 1.08) Ref. 0.09 (−1.33, 1.51) −0.82 (−2.66, 1.02)
LVMI, g/m2 Ref. −2.09 (−4.21, 0.02) 4.97 (2.24, 7.69) Ref. −1.73 (−3.69, 0.22) 5.24 (2.71, 7.77)
LV mass / volume Ref. 0.01 (−0.04, 0.06) 0.10 (0.04, 0.17) Ref. 0.01 (−0.03, 0.06) 0.12 (0.06, 0.18)
LV Strain#
    Total Strain, % Ref. 0.02 (−0.36, 0.41) 0.56 (0.07, 1.06) * Ref. 0.01 (−0.37, 0.38) 0.74 (0.26, 1.22)
    Base Strain, % Ref. 0.08 (−0.39, 0.55) 0.60 (−0.01, 1.20) Ref. 0.08 (−0.38, 0.55) 0.71 (0.12, 1.31) *
    Mid Strain, % Ref. −0.13 (−0.63, 0.38) 0.50 (−0.15, 1.15) Ref. −0.16 (−0.66, 0.33) 0.71 (0.07, 1.34) *
    Apex Strain, % Ref. 0.16 (−0.31, 0.63) 0.61 (0.01, 1.21) * Ref. 0.14 (−0.32, 0.59) 0.82 (0.23, 1.41)
PWV, m/sec Ref. 0.23 (−0.65, 1.12) 1.42 (0.27, 2.57) * Ref. 0.24 (−0.64, 1.12) 1.25 (0.09, 2.41) *

LVEDV: left ventricular end-diastolic volume, LVEF: left ventricular ejection fraction, LVESV: left ventricular end-systolic volume, LVMI: left ventricular mass index, PWV: pulse wave velocity from ascending aorta to descending aorta. #: Strain indicators represent mean peak systolic circumferential strain. Visit 3 smoking status information was used for the analysis. Model 1: adjusted for age and sex. Model 2: further adjusted for systolic blood pressure, anti-hypertensive medication use, body mass index, diabetes, and estimated glomerular filtration rate.

*:

p<0.05

†:

p<0.01.